Aspen Pharmacare Holdings (JSE:APN) EPS (Basic): R-4.51 (TTM As of Dec. 2025)


JSE:APN Aspen Pharmacare Holdings Ltd JSE:APN
73 GF Score
Price R151.70
GF Value R178.18
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings EPS (Basic)?

Aspen Pharmacare Holdings JSE:APN +0.26% 73 EPS (Basic) is R-4.51 as of Dec. 2025. GuruFocus rates JSE:APN with a GF Score™ of 73/100 and a GF Value™ of R178.18 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Aspen Pharmacare Holdings's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was R3.31. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was R-4.51.

Aspen Pharmacare Holdings's EPS (Diluted) for the six months ended in Dec. 2025 was R3.31. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was R-4.51.

Aspen Pharmacare Holdings's EPS without NRI for the six months ended in Dec. 2025 was R3.84. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 9.30.

During the past 12 months, Aspen Pharmacare Holdings's average EPS without NRIGrowth Rate was -29.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -13.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -0.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Aspen Pharmacare Holdings's highest 3-Year average EPS without NRI Growth Rate was 365.50% per year. The lowest was -13.40% per year. And the median was 17.85% per year.

Aspen Pharmacare Holdings  (JSE:APN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Aspen Pharmacare Holdings EPS (Basic) Related Terms

Aspen Pharmacare Holdings EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings EPS (Basic) Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.53 14.32 11.77 9.91 -2.44

Aspen Pharmacare Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.21 4.71 5.38 -7.82 3.31
JSE:APN
73GF Score
Aspen Pharmacare Holdings Ltd JSE:APN
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aspen Pharmacare Holdings's Basic EPS for the fiscal year that ended in Jun. 2025 is calculated as

Basic EPS (A: Jun. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1083-0)/444.000
=-2.44

Aspen Pharmacare Holdings's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1472-0)/444.600
=3.31

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was R-4.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of R-4.51 mean?
Aspen Pharmacare Holdings (JSE:APN) has a EPS (Basic) of R-4.51 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aspen Pharmacare Holdings and its competitors.
Is Aspen Pharmacare Holdings' EPS (Basic) too high?
Aspen Pharmacare Holdings' current EPS (Basic) is R-4.51. Overall, Aspen Pharmacare Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' EPS (Basic) compare to ZTS and UTHR?
Aspen Pharmacare Holdings' EPS (Basic) of R-4.51 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aspen Pharmacare Holdings and its competitors. Aspen Pharmacare Holdings's current EPS (Basic) is R-4.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (JSE:APN) is currently considered Modestly Undervalued. The stock's GF Value™ is R178.18, compared to a current price of R151.70 — trading 14.9% below its estimated fair value. The current EPS (Basic) is R-4.51. Aspen Pharmacare Holdings' overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Aspen Pharmacare Holdings (JSE:APN), the current EPS (Basic) is R-4.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of R151.70 is trading 14.9% below its estimated GF Value™ of R178.18. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for JSE:APN:

  • EPS (Basic): R-4.51
  • GF Value™: R178.18 vs. price of R151.70 (14.9% below fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
73GF Score

Get the complete analysis for JSE:APN

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R151.70
Price
R178.18
GF Value